Autonomix Medical is a developer of a novel technology designed to bring clarity to minimally invasive renal denervation to treat heart disease. Its technology is used to develop minimally invasive neural monitoring and treatment devices for next-generation neuromodulation therapies that enable medical practitioners to accurately assess and treat peripheral and neural mediated disease. The company develops a proprietary microchip, hardware, and software which can be integrated into a catheter or other device to dramatically improve electrophysiologic signal fidelity and simplify data analysis. It was founded in 2014 and is headquartered in Excelsior, Minnesota.